The Gross Margin of Atara Biotherapeutics, Inc. (ATRA) is
82.44%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date |
Value |
| 2025-12-31 |
82.44%
|
| 2024-12-31 |
83.71%
|
| 2023-12-31 |
-3.65%
|
| Ticker |
Name |
Value |
|
AMGN
|
Amgen Inc
|
70.78%
|
|
NWBO
|
Northwest Biotherapeutics Inc
|
100.00%
|
|
PCVX
|
Vaxcyte, Inc.
|
7775.20%
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
86.24%
|
|
KNSA
|
Kiniksa Pharmaceuticals International, PLC
|
88.54%
|
|
ORIC
|
ORIC Pharmaceuticals, Inc.
|
7775.20%
|
|
TSHA
|
Taysha Gene Therapies, Inc.
|
7775.20%
|
|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
90.24%
|
|
EPIX
|
ESSA Pharma Inc
|
7775.20%
|
|
FDMT
|
4D Molecular Therapeutics Inc
|
7775.20%
|
|
AKRO
|
Akero Therapeutics Inc
|
7775.20%
|
|
ITOS
|
iTeos Therapeutics Inc
|
7775.20%
|
|
PRAX
|
Praxis Precision Medicines, Inc.
|
7775.20%
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
86.56%
|
|
SNDX
|
Syndax Pharmaceuticals, Inc.
|
95.96%
|
|
YMAB
|
Y-mAbs Therapeutics Inc
|
82.89%
|
|
ABBV
|
AbbVie Inc.
|
71.62%
|
|
AVXL
|
Anavex Life Sciences Corp
|
7775.20%
|
|
DVAX
|
Dynavax Technologies Corp
|
82.17%
|
|
PASG
|
Passage Bio Inc
|
7775.20%
|
|
950220.KQ
|
Neoimmunetech Inc
|
7775.20%
|
|
MRSN
|
Mersana Therapeutics Inc
|
7775.20%
|
|
STOK
|
Stoke Therapeutics, Inc.
|
7775.20%
|
|
KROS
|
Keros Therapeutics, Inc.
|
7775.20%
|
|
MRNA
|
Moderna, Inc.
|
70.32%
|
|
950160.KQ
|
Kolon TissueGene Inc
|
13.28%
|
|
ARCT
|
Arcturus Therapeutics Holdings Inc
|
7775.20%
|
|
CYDY
|
Cytodyn Inc
|
-27547.74%
|
|
GILD
|
Gilead Sciences, Inc.
|
78.84%
|
|
KNTE
|
Kinnate Biopharma Inc
|
7775.20%
|
|
RYTM
|
Rhythm Pharmaceuticals, Inc.
|
89.73%
|
|
950200.KQ
|
Psomagen Inc
|
24.48%
|
|
ANNX
|
Annexon, Inc.
|
7775.20%
|
|
BTAI
|
BioXcel Therapeutics Inc
|
74.45%
|
|
CMPS
|
Compass Pathways PLC
|
7775.20%
|